Insight Molecular Diagnostics Reports Q3 Earnings Beat on Revenue and EPS

Insight Molecular Diagnostics Inc. (IMDX) reported third-quarter financial results that exceeded analyst expectations for both earnings per share and revenue. The company posted a GAAP EPS of -$0.10, which outperformed estimates by $0.14, and recorded revenue of $0.56 million, surpassing consensus by $0.32 million. The company demonstrated significant year-over-year growth, with revenue increasing by 115.4%. As of the reporting period, Insight Molecular Diagnostics held $11.02 million in cash and cash equivalents. Despite the earnings beat, the stock saw a slight decline of 1.08% in after-hours trading.

By https://seekingalpha.com/user/63224816/bio · Seeking Alpha ·

Insight Molecular Diagnostics Reports Q3 Earnings Beat on Revenue and EPS

Tickers: $IMDX

Topics: earnings beat GAAP EPS revenue growth

Read the full article at Seeking Alpha

More World news